Farmafleur SRL
1.9 FTEFarmafleur reported total assets of 542,076 € at the end of the 2026 financial year (annual accounts filed with the NBB on 26 Oct 2026), with 1.9 full-time equivalent.
The score of Farmafleur shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +1 % Total assets -11 % Headcount (avg FTE) -17 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmafleur's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 26 Oct 2026
- Year ended 31 Mar 2025filed on 24 Oct 2025
- Year ended 31 Mar 2024filed on 30 Oct 2024
- Year ended 31 Mar 2023filed on 30 Oct 2023
- Year ended 31 Mar 2022filed on 02 Nov 2022
Farmafleur's financial analysis
- Solvency33.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmafleur
Farmafleur's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0894.786.891
- VAT number
- BE0894786891
- Peppol
- Registered · 0208:0894786891 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Dec 2007
- Registered office
- 2180 Antwerp
- Size
- Micro · 1.9 FTE
- Latest accounts
- 2026 · filed on 26 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Farmafleur (SRL) has been based in Antwerp since 2007, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 103 € and equity of 180,417 €; its revenue is not published. With 1.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 33.3%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Farmafleur
Companies in the same business, of comparable size and area, outside its group.
- APLV Retail sale of pharmaceutical products Bornem · balance sheet 542,377 €
- Apotheek Browaeys Retail sale of pharmaceutical products Kluisbergen · balance sheet 541,697 €
- Pharmacie New Europa Retail sale of pharmaceutical products Auderghem · balance sheet 542,525 €
- ST Farma Retail sale of pharmaceutical products Ghent · balance sheet 539,584 €
- Bankapotheek Retail sale of pharmaceutical products Antwerp · balance sheet 538,658 €
- Gilis-Segers Retail sale of pharmaceutical products Tienen · balance sheet 545,887 €
- Farmapunt Maaseik Retail sale of pharmaceutical products Hamont-Achel · balance sheet 536,437 €
- Pharma Stubbe Retail sale of pharmaceutical products Ingelmunster · balance sheet 535,694 €
Frequently asked questions about Farmafleur
What is the revenue of Farmafleur?
Farmafleur files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Farmafleur?
In Belgium, the VAT number is the company number prefixed with BE: BE0894786891 for Farmafleur, if the company is VAT-registered. Its company number (CBE) is 0894.786.891.
Where is the registered office of Farmafleur?
According to the CBE register, the registered office of Farmafleur is in 2180 Antwerp.
What is the equity of Farmafleur?
At the close of the 2026 financial year, the equity of Farmafleur amounts to 180,417 €, a solvency of 33.3% of total assets.
How many people work at Farmafleur?
1.9 full-time equivalents on average according to the 2026 social balance sheet.
Who manages Farmafleur?
The register lists 1 active mandates at Farmafleur. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmafleur
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →